Health Care
Morgan Stanley among investors buying stake in Turkish drugmaker

(Bloomberg) –Morgan Stanley and a group of investors are close to buying 30% of Turkish drugmaker Sanovel Ilac Sanayi ve Ticaret AS, according to people with knowledge of the matter.
London-based buyout firm Metric Capital Partners LLP is also part of the consortium that will pay almost $200 million for the stake in the producer of anti-inflammatory, anti-asthmatic and antibiotic medication, said the people, asking not to be identified because the information isn’t public.
Read: Novartis agrees to buy Medicines Co. in $6.8 billion deal
Representatives for Sanovel, Morgan Stanley and Metric Capital declined to comment. The deal is due to be signed next week, the people said.
The deal follows a failed attempt by Sanovel’s owners, Turkish businessmen Ahmet Toksoz and Zafer Toksoz, to sell a minority holding to Abraaj Group in 2018. The Dubai-based buyout firm, which once managed about $14 billion as the developing world’s most influential private equity investor, was forced into liquidation after mismanaging investor funds.
-
News1 month ago
Offer Price, Overview, Investors: Here’s Everything You Need to Know About Asyad Shipping’s Mega IPO
-
OER Magazines2 months ago
OER, January 2025
-
Alamaliktistaad Magazines2 months ago
Al-iktisaad, January 2025
-
Automotive1 month ago
[REVIEW] A Legend Reinvented: The Nissan Patrol Y63 Blends Heritage with Modern Mastery
-
OER Magazines4 weeks ago
OER, February 25
-
Alamaliktistaad Magazines4 weeks ago
Al-iktisaad, February 2025
-
Manufacturing2 months ago
JSIS Promotes Steel Slag for Sustainable Construction Practices
-
Energy1 month ago
Dubai Supreme Council of Energy Unveils 5th Emirates Energy Award 2023–2025 in Muscat